Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Short-term Investments (2023 - 2025)

Genenta Science S.p.A (GNTA) posted Short-term Investments of $26.3 million for Q4 2025, up 86.22% sequentially from $14.1 million in Q2 2025, and up 205.05% YoY from $8.6 million in Q4 2024.

Genenta Science S.p.A (GNTA) Short-term Investments (2023 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Short-term Investments for 3 years, with the latest figure at $26.3 million in Q4 2025.

  • Quarterly Short-term Investments rose 205.05% year-over-year to $26.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.3 million (up 205.05% YoY) and the FY2025 annual result came in at $26.3 million, up 205.05% from the prior year.
  • Short-term Investments rose to $26.3 million in Q4 2025 per GNTA's latest filing, from $14.1 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $26.3 million in Q4 2025 and troughed at $8.6 million in Q4 2024.
  • A 3-year average of $14.6 million and a median of $12.8 million in 2024 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2024 and 2025: Short-term Investments plunged 46.81% in 2024, then soared 205.05% in 2025.
  • Over 3 years, Short-term Investments stood at $16.2 million in 2023, then tumbled by 46.81% to $8.6 million in 2024, then jumped by 205.05% to $26.3 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods registered $26.3 million, $14.1 million, and $8.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 26.33 Mn
Jun 30, 2025 14.14 Mn
Dec 31, 2024 8.63 Mn
Jun 30, 2024 11.54 Mn
Dec 31, 2023 16.23 Mn
Jun 30, 2023 10.89 Mn